Experimental basis for cancer prevention by vitamin E

Cancer Investigation

Volumn 18, Issue 3, 2000, Pages 214-222

  Shklar, Gerald ^a   Oh, Se Kyung ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

CANCER EPIDEMIOLOGY; CANCER IMMUNOLOGY; CANCER PREVENTION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG SELECTIVITY; EVIDENCE BASED MEDICINE; FOOD DRUG INTERACTION; HUMAN; NONHUMAN; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; VITAMIN SUPPLEMENTATION;

EID: 0034108379     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009031826     Document Type: Review

References (103)

1. Benner SC, Winn RJ, Lippman SM, et al: Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program. Chemopreventative study. S Natl Cancer Inst 85: 44-48, 1993.
2. Garewal HS: Beta-carotene and vitamin E in oral cancer prevention. J Cell Biochem 17F:262-269, 1993.
3. Blot WJ, Li J, Taylor PR, et al: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. J Nat Cancer Inst 85:1483-1491, 1993.
4. Heinonen OP, Albanes D, Virtamo J, et al: Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90:440-446, 1998.
5. Shklar G: Experimental pathology of oral cancer. In: Oral Cancer, edited by G Shklar, Philadelphia, W.B. Sauners Co., 1984.
6. Shklar G: The effect of manipulation and incision on experimental carcinoma of hamster buccal pouch. Cancer Res 28:2180-2182, 1986.
7. Shin DM, Gimenez-Conti IB, Lee JS, et al: Expression of epidermal growth factor receptor, polyamine levels, ornothine decarboxylase activity, micronuclei, and transglutaminase 1 in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model. Cancer Res 50:2505-2510, 1990.
8. Solt DB: Localization of gamma-glutamyl-transpeptidase in hamster buccal pouch epithelium treated with 7,12-dimethylbenz(a)anthracene. J Nat Cancer Inst 67:193-197, 1981.
9. Salley JJ: Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res 33:263-262, 1954.
10. Shklar G: Experimental oral pathology in the Syrian hamster. Prog Exper Tumor Res 16:518-538, 1972.
11. Gimenez-Conti B, Slaga TJ: The hamster cheek pouch carcinogenesis model. J Cell Biochem 17F:83-90, 1993.
12. Shklar G, Meyer I, Stevens W, et al: A variance in hamster pouch carcinogenesis in tissue irradiated with 200 KVP x-rays and cpbalt-60 x-rays. Oral Surg 30:431-437, 1970.
13. Sheehan R, Shklar G, Tennenbaum R: Azathioprine effects on the developmant of hamster pouch carcinomas. AMA Arch Pathol 91:264-270, 1971.
14. Woods DA: Influence of antilymphocyte serum on DMBA induction of oral carcinomas. Nature 224:276-277, 1969.
15. Santis H, Shklar G, Chauncey H: The histochemistry of experimentally induced leukoplakia and carcinoma of the hamster buccal pouch. Oral Surg 17:84-95, 1964.
16. Salley JJ: Histologic changes in the hamster cheek pouch during early hydrocarbon carcinogenesis. J Dent Res 36:48-54, 1957.
17. Malament DS, Shklar G: Inhibition of DMBA carcinogenesis of Hamster buccal pouch by phenanthrene and dimethylnapthalene. Carcinogenesis 2:723-729, 1981.
18. Shklar G: Metabolic characteristics of experimental hamster pouch carcinomas. Oral Surg 20:336-341, 1965.
19. Solt D, Shklar G: Rapid induction of gamma-glutamyl transpeptidase - rich intraepithelial clones in 7,12-dimethylbenz(a)anthracene treated hamster buccal pouch. Cancer Res 42: 285-295, 1982.
20. Wong DTW, Biswas DK: Expression of c-erb B oncogene in DMBA-induced hamster oral carcinomas. Oncogene 2:67-72, 1987.
21. Wong D: Amplification of c-erb-B proto-oncogene during dimethylbenzanthracene-induced tumorigenesis in hamster cheek pouch. Oncogene 2:67-72, 1987.
22. Wong DTW, Gertz R, Chow P, et al: Detection of Ki-ras messenger RNA in normal and chemically transformed hamster oral keratinocytes. Cancer Res 49:4562-4567, 1989.
23. Husain Z, Fei YB, Roy S, et al: Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in in vivo chemical carcinogenesis. Proc Natl Acad Sci USA 86:1264-1268, 1989.
24. Kwong YY, Husain Z, Biswas DK: c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis. Oncogene 7:1481-1489, 1992.
25. Wong DTW: TGFα and oral carcinogenesis. Oral Oncol Eur J Cancer 29B:3-7, 1993.
26. Silverman S, Shillitoe EJ: Etiology and predisposing factors. In: Oral Cancer, edited by Silverman, S. Atlanta, American Cancer Society, 1990.
27. Altuwairgi OS, Papageorge MB, Doku HC: The cancer-promoting effect of n-nitrosonornicotine used in combination with a subcarcinogenic dose of 4-nitroquinoline-n-oxide and 7,12-dimethylbenz(a)anthrace. J Oral Maxillofac Surg 53:910-913, 1995.
28. Freedman A, Shklar G: Alcohol and hamster buccal pouch carcinogenesis. Oral Surg 46:794-805, 1978.
29. Steele C, Shillitoe EJ: Viruses and oral cancer. Crit Rev Oral Biol Med 2:153-175, 1991.
30. Brandama JL, Abramson AL: Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115:621-625, 1989.
31. Oh JS, Cherrick HM, Park N-H: Effect of snuff extract on the replication and synthesis of viral DNA and proteins in cells infected with Herpes simplex virus. J Oral Maxillofac Surg 48: 373-379, 1990.
32. Oh JS, Paik D, Christensen R, et al: Herpes simplex virus enhances the 7,12-dimethylbenz(a)antracene (DMBA) induced carcinogenesis and amplification and overexpression of c-erb-B-1 proto-oncogene in hamster buccal pouch epithelium. Oral Surg 68:428-435, 1989.
33. Park N-H, Min B-M, Li S-L, et al: Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1:1627-1631, 1991.
34. Odukoya O, Shklar G: Initiation and promotion in experimental oral carcinogenesis. Oral Surg 58:315-323, 1984.
35. Shklar G, Cataldo E, Fitzgerald AL: The effect of methotrexate on chemical carcinogenesis of hamster buccal pouch. Cancer Res 26:2218-2224, 1966.
36. Shklar G: Cortisone and hamster buccal pouch carcinogenesis. Cancer Res 26:2461-2463, 1996.
37. Giunta J, Reif AE, Shklar G: Bacillus Calmette-Guerin and anti-lymphocyte serum in carcinogenesis. Arch Pathol 98:237-240, 1974.
38. Eisenberg E, Shklar G: Levamisole and hamster buccal pouch carcinogenesis. Oral Surg 43:562-571, 1977.
39. Shklar G, Eisenberg E, Flynn E: Immunoenhancing agents and experimental leukoplakia and carcinoma of the hamster buccal pouch. Prog Exper Tumor Res 24:269-282, 1979.
40. Shklar G: Inhibition of oral mucosal carcinogenesis by vitamin E. J Natl Cancer Inst 68:791-797, 1987.
41. Trickler D, Shklar G: Prevention by vitamin E of oral carcinogenesis. J Nat Cancer Inst 78:165-169, 1987.
42. Shklar G, Schwartz JL, Trickler D, et al: Regression by vitamin E of experimental oral cancer. J Natl Cancer Inst 8:987-992, 1987.
43. Davidson JR: An attempt to inhibit the development of tar-carcinomata in mice. Can Med Assn J 31:486-487, 1934.
44. Telford IR: The effects of hypo-and hypervitaminosis E in lung tumor growth in mice Ann N Y Acad Sci 52:132-134, 1949.
45. Harman D: Dimethylbenzanthracene-induced cancer. Inhibiting effect of dietary vitamin E. Clin Res 17:125-129, 1969.
46. Slaga TJ, Bracken WM: The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase. Cancer Res 37: 1831-1835, 1977.
47. Cook MG, McNamara P: Effect of dietary vitamin E on dimethylhydrazine-induced colonie tumors in mice. Cancer Res 40: 1329-1332, 1980.
48. Shklar G, Schwartz JL, Trickler D, et al: Prevention of experimental cancer and immunostimulation by vitamin E (immunosurveillance). J Oral Pathol Med 19:60-64, 1990.
49. Schwartz JL, Shklar G, Trickler D: p53 in the anticancer mechanism of vitamin E. Oral Oncol Eur J Cancer 29B:313-318, 1993.
50. Shklar G, Schwartz JL: Vitamin E inhibits experimental carcinogenesis and tumor angiogenesis. Oral Oncol Eur J Cancer 32B: 114-119, 1996.
51. Shklar G, Schwartz JL: Tumor necrosis factor in experimental cancer: regression with alpha tocopherol, beta carotene, and algae extract. Eur J Cancer Clin Oncol 24:839-850, 1988.
52. Schwartz J, Odukoya O, Stouti E, et al: Alpha tocopherol alters the distribution of Langerhans cells in DMBA treated hamster cheek pouch epithelium. J Dent Res 64:117-121, 1985.
53. Burnet F: The concept of immunologic surveillance. Prog Exper Tumor Res 13:1-20, 1970.
54. Lane DP: p53 guardian of the genome. Nature 358:15-16, 1992.
55. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Nat Cancer Inst 82:4-6, 1989.
56. Shklar, G, Schwartz JL: A common pathway for the destruction of cancer cells: experimental evidence and clinical implications. Int J Oncol 4:215-224, 1944.
57. Shklar G, Schwartz JL, Trickier DP, et al: Regression of experimental cancer by oral administration of combined alpha tocopherol and beta carotene. Nutr Cancer 12:321-325, 1989.
58. Palozza P, Krinsky NI: Beta carotene and a-tocopherol are synergistic antioxidants. Arch Biochem Biophys 297:184-187, 1992.
59. Shklar G, Schwartz JL, Trickler DP, et al: The effectiveness of a mixture of beta carotene, alpha tocopherol, glutathione and ascorbic acid for cancer chemoprevention. Nutr Cancer 20:145-151, 1993.
60. Trickler D, Shklar G, Schwartz J : Inhibition of oral carcinogenesis by glutathione. Nutr Cancer 20:139-144, 1993.
61. Schwartz JL, Shklar G: The selective cytotoxic effect of carotenoids and alpha tocopherol on human cancer cell lines in vitro. J Oral Maxillofac Surg 50:367-373, 1992.
62. Schwartz JL, Tanaka V, Khandekar V, et al: Beta carotene and/ or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells. Cancer Chemother Parmacol 29: 207-213, 1991.
63. Bendich AB, Machlin LJ: Safety of oral intake of vitamin E. Am J Clin Nutr 48:612-619, 1988.
64. Meydani SN, Meydani M, Rall LC, et al: Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. Am J Clin Nutr 60:704-709, 1994.
65. Burtun GW, Ingold KU: Vitamin E as an in vitro and in vivo antioxidant. Ann N Y Acad Sci 587:24-33, 1990.
66. Irani K, Xia Y, Zweier JL, et al: Mitogenic signalling mediated by oxidants in Ras-transformed tibroblasts. Science 275:1649-1652, 1997.
67. Lowy DR, Willumsen BM: Function and regulation of ras. Annu Rev Biochem 62:851-891, 1993.
68. Rotruck JT, Pope AL, Ganther HE, et al: Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588-590, 1973.
69. Kayanoki Y, Fujii J, Islam KN, et al: The protective role ot glutathione peroxidase in apoptosis induced by reactive oxygen species. J Biochem 119:817-822, 1996.
70. Gallegos A, Berggren M, Gasdaska JR, et al: Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57:4965-4970, 1997.
71. Liebler DC, Kaysen KL, Burr JJ: Peroxyl radical trapping and autooxidation reactions of alpha-tocopherol in lipid bilayers, Chem Res Toxicol 4:89-93, 1991.
72. McCay PB, Poyer JL, Pfeifer PM, et al: A function of α-tocopherol: stabilization of the microsomal membrane from radical attack during TPNH-dependent oxidations. Lipids 6:297-306, 1971.
73. Lyer GYN, Islam DMF, Quastel JH: Biochemical aspects of phagocytosis. Nature 192:535-541, 1961.
74. Azzi AM, Bartoli G, Boscoboinik D, et al: Alpha-tocopherol and protein kinase C regulation of intracellular signalling. In: Vitamin E in Health and Disease, edited by L Packer J Fuchs, New York, Marcel Dekker, 1993, pp. 371-383.
75. Turley JM, Ruscetti FW, Kim SJ, et al: Vitamin E succinate inhibits proliferation of B-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res 57:2668-2675, 1997.
76. Zhao B, Yu W, Qian M, et al: Involvement of activator protein-1 (AP-1) in the induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol Carcinogen 19:180-190, 1997.
77. Kaplowitz N, Yoshida H, Kuhlenkamp J, et al: Tocopherol-binding proteins of hepatic cytosol. Ann N Y Acad Sci 570:85-94, 1989.
78. McCay PB: Vitamin E: interactions with free radicals and ascorbate. Annu Rev Nutr 5:323-340, 1985.
79. Scarpa M, Rigo A, Maiorino M, et al: Formation of α-tocopherol radical and recycling of α-tocopherol by ascorbate during peroxidation of phosphatidylcholine liposomes. An electron paramagnetic resonance study. Biophys Acta 801:215-219, 1984.
80. Schwartz J, Shklar G, Trickler D: Vitamin C enhances the development of carcinomas in the hamster buccal pouch experimental model. Oral Surg 76:718-722, 1993.
81. Banic S: Vitamin C acts as a cocarcinogen to methylcholanthrene in guinea pigs. Cancer Lett 11:239-242, 1981.
82. Menkes MS, Comstock GW, Vuilleumier JP, et al: Serum beta carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 315:1250-1254, 1986.
83. Palan PR, Mikhail MS, Basu J, et al: Plasma levels of antioxidant β-carotene and α-tocopherol in uterine cervix dysplasia and cancer. Nutr Cancer 15:13-20, 1991.
84. Eichholzer M, Stahelin HB, Gey KF, et al: Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basle study. Int J Cancer 66: 145-150, 1996.
85. Meydani SN, Metdani M, Blumberg JB, et al: Vitamin E supplementation and in vivo immune response in healthy elderly subjects. JAMA 277:1380-1386, 1997.
86. Duthie SJ, Ma A, Ross MA, et al: Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 56:1291-1295, 1996.
87. Stephens NG, Parsons A, Schofield PM, et al: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786, 1996.
88. Jain SK, McVie R, Jaramillo JJ, et al: The effect of modest vitamin E supplementation on lipid peroxidation and other cardiovascular risk factors in diabetic patients. Lipids 31:S87-S90, 1996.
89. Fahn S: An open trial of high-dosage antioxidants in early Parkinson's disease. Am J Clin Nutr 53:380S-382S, 1991.
90. Factor SA, Weiner WJ: Retrospective evaluation of vitamin E therapy in Parkinson's disease. Ann N Y Acad Sci 570:441-442, 1989.
91. Peet M, Laugharne J, Rangarajan N, et al: Tardive dyskinesia, lipid peroxidation and sustained amelioration with vitamin E treatment, Int Clin Psychopharmacol 8:151-153, 1993.
92. Lohr JB, Caliguri MP: A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Pyschiatry 57:167-173, 1996.
93. Sano M, Ernesto C, Thomas RG, et al: A controlled trial of selegiline, alpha-tocopherol or both as treatment for Alzheimer' s disease. N Engl J Med 336:1216-1222, 1997.
94. Ogunmekan AO, Hwang PA: A randomized double-blind, placebo-controlled, clinical trial of d-alpha-tocopherol acetate (vitamin E), as add-on therapy, for epilepsy in children. Epilepsia 30:84-89, 1989.
95. Moriguchi S, Maekawa K, Okamura M, et al: Vitamin E prevents the decrease of cellular immune function with aging in spontaneously hypertensive rats. Nutr Res 15:401-414, 1995.
96. Hayek MG, Taylor SF, Bender BS, et al: Vitamin E supplementation decreases lung virus titers in mice infected with influenza. J Infect Dis 176:273-276, 1997.
97. Xu H, Watkins BA, Seifert MF: Vitamin E stimulates trabecular bone formation and allers epiphysial cartilage morphometry. Calcif Tissue Int 57:293-300, 1995.
98. Wang YM, Madanat FF, Kimball JC, et al: Effect of vitamin E against adriamycin induced toxicity in rabbits. Cancer Res 40: 1022-1026, 1980.
99. Sonis S, Tracey C, Shklar G, et al: An animal model for the mucositis of chemotherapy. Oral Surg 69:437-443, 1990.
100. Wong DTW, Todd R, Tsuji T, et al: Molecular biology of human oral cancer. Crit Rev Oral Med Biol 7:319-328, 1996.
101. Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor a and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579-3584, 1993.
102. Spandidos DA, Lamothe A, Field JK: Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumors. Anticancer Res 5:221-224, 1995.
103. Silverberg E, Boring CC, Squires TS: Cancer statistics 1990. CA J Am Cancer Soc 40:9-26, 1990.